Nanaomycins, new antibiotics produced by a strain of Streptomyces. I. Taxonomy, isolation, characterization and biological properties.
Nanomycins are new antibiotics produced by the strain OS-3966 which was designated Streptomyces rosa var. notoensis. Nanomycins A and B were isolated from the culture filtrate by extraction with organic solvent and silica gel chromatography. The physical and chemical properties suggest that nanaomycins A and B are quinone-related compounds having the molecular formulae, C16H14O6 and C16H16O7, respectively. Nanaomycins A and B inhibit mainly mycoplasmas, fungi and Gram-positive bacteria. The acute toxicities (LD50, ip) of nanaomycins A and B in mice are 28.2 and 169 mg/kg, respectively.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000145:classification / Q000302:isolation & purification / Q000494:pharmacology; D007928:Lethal Dose 50; D051379:Mice; D009174:Mycoplasma / Q000187:drug effects; D011809:Quinones / Q000145:classification / Q000302:isolation & purification / Q000494:pharmacology; D013211:Staphylococcus aureus / Q000187:drug effects; D013302:Streptomyces / Q000378:metabolism*; D014249:Trichophyton / Q000187:drug effects
D000900:Anti-Bacterial Agents; D011809:Quinones